CVS Health [NYSE: CVS] President and CEO Larry Merlo will share his insights on the accelerated pace of change in health care and vision for transforming America’s $3.6 trillion health care system during a gathering of Town Hall Los Angeles, the city’s oldest and largest public speaking forums for presenting solutions to the most relevant issues affecting the Los Angeles community.
“Today’s health care system has become increasingly fragmented and too complex for people to navigate and afford. And without true innovation, more Americans will simply be without health care in the future,” said Merlo. “I’m looking forward to sharing with leaders from across Los Angeles the many ways our company is transforming health care today, and our even more ambitious journey to lead the change that is needed more broadly in American health care in the future.”
During his remarks, Merlo will highlight how the combination of CVS Health and Aetna, one of the nation’s leading diversified health care benefits companies, will combine data-driven insights, new digital technologies, and the convenience of local community-based care to establish a new health care delivery model that is easier to use, less expensive and puts consumers at the center of their care.
Merlo is scheduled to make his remarks on Thursday, September 20, 11:30 a.m.-1:30 p.m., at the City Club of Los Angeles. To attend the event, visit Town Hall Los Angeles.
Town Hall Los Angeles is a non-profit, nonpartisan speaker’s forum, providing a vital platform for discussing and debating today’s most pressing issues. One of the Top 10 Leadership Forums in the nation, Town Hall is dedicated to promoting civic participation in the Los Angeles community. In a world of sound bites, Town Hall embodies the values of a democracy and the role of an engaged citizenry.
About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,800 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 94 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.
Contacts:
Media Contact:
Joe Goode, 401-770-9820
Joseph.Goode@CVSHealth.com
Investor Relations:
Mike McGuire, 401-770-4050
Michael.McGuire@CVSHealth.com
No Offer or Solicitation
This communication is for informational purposes only and not intended to and does not constitute an offer to subscribe for, buy or sell, the solicitation of an offer to subscribe for, buy or sell or an invitation to subscribe for, buy or sell any securities or the solicitation of any vote or approval in any jurisdiction pursuant to or in connection with the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.
Additional Information and Where to Find It
In connection with the proposed transaction between CVS Health Corporation (“CVS Health”) and Aetna Inc. (“Aetna”), CVS Health filed a registration statement on Form S-4 with the Securities and Exchange Commission (the “SEC”), which includes a joint proxy statement of CVS Health and Aetna that also constitutes a prospectus of CVS Health. The registration statement was declared effective by the SEC on February 9, 2018, and CVS Health and Aetna commenced mailing the definitive joint proxy statement/prospectus to stockholders of CVS Health and shareholders of Aetna on or about February 12, 2018, and the special meeting of the stockholders of CVS Health and the shareholders of Aetna was held on March 13, 2018. INVESTORS AND SECURITY HOLDERS OF CVS HEALTH AND AETNA ARE URGED TO READ THE DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders may obtain free copies of the registration statement and the definitive joint proxy statement/prospectus and other documents filed with the SEC by CVS Health or Aetna through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by CVS Health are available free of charge within the Investors section of CVS Health’s Web site at http://www.cvshealth.com/investors or by contacting CVS Health’s Investor Relations Department at 800-201-0938. Copies of the documents filed with the SEC by Aetna are available free of charge on Aetna’s internet website at http://www.Aetna.com or by contacting Aetna’s Investor Relations Department at 860-273-0896.
SOURCE CVS Health